‘It’s all about chance and good luck!’

Symptoms appeared at the age of 5 years, but he got diagnosed 10 years later

March 06, 2017 01:10 am | Updated 01:10 am IST - NEW DELHI

GHAZIABAD, UTTAR PRADESH, 03/03/2017: Shashank Tyagi who is suffering from a rare genetic disorder 'Gaucher' at his residence in Raj Nagar, Ghaziabad in Uttar Pradesh on Friday.
Photo: R.V. Moorthy

GHAZIABAD, UTTAR PRADESH, 03/03/2017: Shashank Tyagi who is suffering from a rare genetic disorder 'Gaucher' at his residence in Raj Nagar, Ghaziabad in Uttar Pradesh on Friday. Photo: R.V. Moorthy

“The cost of my Enzyme Replacement Therapy (ERT) alone is ₹1.3 crore a year. It’s taken care of by a charitable venture. However, my symptomatic treatment, diet chart, bone issues and eye treatment have to be treated and paid for separately. Gaucher’s disease, one of the diseases under the LSDs [lysosomal storage diseases] umbrella is an expensive ailment to treat. Those diagnosed with it have to stick to a life-long treatment plan,” said 26-year-old MBA graduate Shashank Tyagi.

‘Awareness is important’

Mr. Tyagi, who works with his businessman father, was diagnosed with Gaucher’s disease at the age of 14 years at the All India Institute of Medical Sciences (AIIMS) after his spleen and liver got enlarged and he developed a protruding abdomen.

“Awareness about rare diseases is very important. My symptoms started appearing in 1995 when I was 5-years-old. However, I got diagnosed in 2004. It took nearly a decade to get an accurate diagnosis as there was no awareness among doctors. Only a few were aware of this condition. If my diagnosis and treatment had happened earlier, I wouldn’t have minor curvature of the spine. I developed the problem due to late treatment and diagnosis. Our main demand now is to get quick access to treatment for diagnosed patients,” he said.

Govt. policy needed

Adding that the government should come up with a policy quickly to help rare diseases patients as it’s impossible to fund your own treatment, he said. “I’m just like any other youngster, but the disease restricts by activity levels. The disease and its life-long handicaps are something I will have to live with. However, everyone should know that screening before birth, early diagnosis and access to medicines are game changers,” said Mr. Tyagi.

He added: “Currently, the treatment and medicines are beyond the reach of the common man. Medicines aren’t available to all. It’s all about chance and good luck! Even the waiting list gives priority to younger children where damage can be minimised. That shouldn’t be the case. You can’t pick and chose who to give life saving medicines to….its just cruel.”

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.